These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10229426)

  • 1. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D; Calin A; Dougados M; Khan MA; van der Linden S; Bellamy N
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.
    van der Heijde D; Bellamy N; Calin A; Dougados M; Khan MA; van der Linden S
    J Rheumatol; 1997 Nov; 24(11):2225-9. PubMed ID: 9375888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
    Wanders AJ; Gorman JD; Davis JC; Landewe RB; van der Heijde DM
    Arthritis Rheum; 2004 Feb; 51(1):1-8. PubMed ID: 14872448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.
    van der Heijde D; van der Linden S; Dougados M; Bellamy N; Russell AS; Edmonds J
    J Rheumatol; 1999 Apr; 26(4):1003-5. PubMed ID: 10229437
    [No Abstract]   [Full Text] [Related]  

  • 5. Instrument selection for the ASAS core outcome set for axial spondyloarthritis.
    Navarro-Compán V; Boel A; Boonen A; Mease PJ; Dougados M; Kiltz U; Landewé RBM; Baraliakos X; Bautista-Molano W; Chiowchanwisawakit P; Dagfinrud H; Fallon L; Garrido-Cumbrera M; Gensler L; ElZorkany BK; Haroon N; Kwan YH; Machado PM; Maksymowych W; Molto A; de Peyrecave N; Poddubnyy D; Protopopov M; Ramiro S; Song IH; van Weely S; van der Heijde D
    Ann Rheum Dis; 2023 Jun; 82(6):763-772. PubMed ID: 35680390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review.
    Bautista-Molano W; Navarro-Compán V; Landewé RB; Boers M; Kirkham JJ; van der Heijde D
    Clin Rheumatol; 2014 Sep; 33(9):1313-22. PubMed ID: 24970597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews.
    Andreasen RA; Kristensen LE; Baraliakos X; Strand V; Mease PJ; de Wit M; Ellingsen T; Hansen IMJ; Kirkham J; Wells GA; Tugwell P; Maxwell L; Boers M; Egstrup K; Christensen R
    Arthritis Res Ther; 2020 Jul; 22(1):177. PubMed ID: 32711571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.
    Spoorenberg A; van Tubergen A; Landewé R; Dougados M; van der Linden S; Mielants H; van de Tempel H; van der Heijde D
    Rheumatology (Oxford); 2005 Jun; 44(6):789-95. PubMed ID: 15757962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review.
    Ruof J; Stucki G
    J Rheumatol; 1999 Apr; 26(4):966-70. PubMed ID: 10229429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics.
    Stone MA; Inman RD; Wright JG; Maetzel A
    Arthritis Rheum; 2004 Jun; 51(3):316-20. PubMed ID: 15188313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessments in ankylosing spondylitis.
    Zochling J; Braun J
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):699-712. PubMed ID: 17678831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
    Akkoc N; van der Linden S; Khan MA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of outcome in ankylosing spondylitis and other spondyloarthritides.
    van der Heijde DM; van der Linden S
    Baillieres Clin Rheumatol; 1998 Nov; 12(4):683-93. PubMed ID: 9928502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experts' beliefs on physiotherapy for patients with ankylosing spondylitis and assessment of their knowledge on published evidence in the field. Results of a questionnaire among international ASAS members.
    Mihai B; van der Linden S; de Bie R; Stucki G
    Eura Medicophys; 2005 Jun; 41(2):149-53. PubMed ID: 16200031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-assessed health in ankylosing spondylitis: a structured review.
    Haywood KL; Garratt AM; Dawes PT
    Rheumatology (Oxford); 2005 May; 44(5):577-86. PubMed ID: 15695297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessments in ankylosing spondylitis.
    Zochling J; Braun J; van der Heijde D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):521-37. PubMed ID: 16777580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
    Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S
    Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10.
    Machado PM; Landewé RB; van der Heijde DM
    J Rheumatol; 2011 Jul; 38(7):1502-6. PubMed ID: 21724723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
    Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
    van der Heijde D; van der Linden S; Bellamy N; Calin A; Dougados M; Khan MA
    J Rheumatol; 1999 Apr; 26(4):945-7. PubMed ID: 10229424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.